CSF rhinorrhea after dopamine agonist treatment for invasive macroprolactinoma.
作者信息
Hildebrandt G
出版信息
Surg Neurol. 1990 Aug;34(2):133. doi: 10.1016/0090-3019(90)90111-2.
PMID:2367933
Abstract
摘要
相似文献
1
CSF rhinorrhea after dopamine agonist treatment for invasive macroprolactinoma.
Surg Neurol. 1990 Aug;34(2):133. doi: 10.1016/0090-3019(90)90111-2.
2
Cerebrospinal fluid (CSF) rhinorrhoea occurring six days after commencement of bromocriptine for invasive macroprolactinoma.
Aust N Z J Med. 2000 Jun;30(3):399-400. doi: 10.1111/j.1445-5994.2000.tb00847.x.
3
[Rhinorrhea and otorrhea: rare complications of the medical treatment in invasive prolactinomas].
Ann Endocrinol (Paris). 1994;54(5):347-51.
4
Notable effect of bromocriptine monotherapy on macroprolactinoma with self-limited cerebrospinal fluid rhinorrhea.
Pol Arch Intern Med. 2019 Dec 23;129(12):927-929. doi: 10.20452/pamw.15095. Epub 2019 Dec 9.
5
Cerebrospinal fluid rhinorrhea occurring in long-term bromocriptine treatment for macroprolactinomas.
Surg Neurol. 1989 Nov;32(5):346-9. doi: 10.1016/0090-3019(89)90137-7.
6
Bromocriptine-induced cerebrospinal fluid fistula in patients with macroprolactinomas: report of three cases and a review of the literature.
Surg Neurol. 1994 Jun;41(6):486-9. doi: 10.1016/0090-3019(94)90013-2.
7
Rhinorrhea following dopamine agonist therapy of invasive macroprolactinoma.
Acta Neurochir (Wien). 1989;96(3-4):107-13. doi: 10.1007/BF01456167.
8
Cerebrospinal fluid rhinorrhea caused by bromocriptine therapy of prolactinoma.
Neurology. 1984 Jan;34(1):111-3. doi: 10.1212/wnl.34.1.111.
9
Cabergoline-induced CSF rhinorrhea in patients with macroprolactinoma. Report of three cases.
J Endocrinol Invest. 2001 Mar;24(3):183-7. doi: 10.1007/BF03343840.
10
Prolactinoma extension as a contributing factor in dopamine agonist-induced CSF rhinorrhea: a systematic review of the literature.
Br J Neurosurg. 2023 Oct;37(5):976-981. doi: 10.1080/02688697.2021.1903389. Epub 2021 Mar 30.
Zotero 插件